Create to address the 'valley of death' between research and commercialisation.
The CSIRO Innovation Fund, managed by Main Sequence, has invested in 39 companies since it was formed in 2017. These companies have created over 1,200 jobs by working with partners in industry, CSIRO, and 22 Australian universities. Main Sequence’s origins within CSIRO reflect its commitment to amplifying connections between industry, research and infrastructure to accelerate deep technology development, and reinvesting economic returns from commercialisation back into science. Companies created with CSIRO include Coviu telehealth platform, Emesent drone technology, RapidAim biosecurity solution, v2food alternative protein, and Nourish Ingredients. You can read more about Main Sequence’s portfolio of investments and the global challenges they’re solving here
Updated almost 3 years ago
Basic Info
| Types | Organization, Business, Government-Sponsored Enterprise, Government Advisory Body |
| Region | Australia and Oceania |